HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esther C Y Lee Selected Research

Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)

1/2021Discovery of Novel, Potent Inhibitors of Hydroxy Acid Oxidase 1 (HAO1) Using DNA-Encoded Chemical Library Screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Esther C Y Lee Research Topics

Disease

3Neoplasms (Cancer)
05/2024 - 01/2021
2Type 2 Diabetes Mellitus (MODY)
02/2014 - 05/2013
1Immune System Diseases (Immune Disorders)
10/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Primary Hyperoxaluria (Oxaluria, Primary)
01/2021
1Metabolic Diseases (Metabolic Disease)
01/2016
1Inflammation (Inflammations)
01/2016
1Obesity
01/2015
1Body Weight (Weight, Body)
01/2015
1Diabetes Mellitus
05/2013

Drug/Important Bio-Agent (IBA)

2Proteolysis Targeting ChimeraIBA
05/2024 - 01/2021
2Glucagon Receptors (Glucagon Receptor)IBA
02/2014 - 05/2013
1Proteins (Proteins, Gene)FDA Link
05/2024
1Adenosine Triphosphatases (ATPase)IBA
03/2024
1Chemokine ReceptorsIBA
10/2021
1CXC ChemokinesIBA
10/2021
1Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
01/2021
1Alkynes (Acetylenes)IBA
01/2021
1AzidesIBA
01/2021
1Hydroxy AcidsIBA
01/2021
1OxalatesIBA
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2021
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
1Aromatase InhibitorsIBA
01/2021
1Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
01/2016
1MelanocortinsIBA
01/2015
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
01/2015

Therapy/Procedure

1Therapeutics
03/2024